1. Harris SR, Templeton E. Who’s listening? Experiences of women with breast cancer in communicating with physicians. Breast J. 2001;7:444–9.
2. Ganz PA. Psychological and social aspects of breast cancer. Oncology (Williston Park). 2008;22:642–6.
3. EMA. Reflection paper on the regulatory guidance for the use of health-related quality of life (HRQL) measures in the evaluation of medicinal products. 2005. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003637.pdf . Accessed 12 July 2016.
4. EMA. Reflection paper on the use of patient reported outcome (PRO) measures in oncology studies. 2014. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/06/WC500168852.pdf . Accessed 12 July 2016.
5. FDA. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims. 2009 [final guidance document]. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf . Accessed 12 July 2016.